EX-23.1 7 f10k2021ex23-1_inmedpharma.htm CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors

 

InMed Pharmaceuticals Inc.:

 

We consent to the incorporation by reference in the Registration Statement (No. 333-253912) on Form S-8 of InMed Pharmaceuticals Inc. (the Company) of our report dated September 24, 2021, with respect to the consolidated financial statements of the Company.

 

 /s/ KPMG LLP

 

Chartered Professional Accountants

 

Vancouver, Canada

September 24, 2021